Upgrade to SI Premium - Free Trial

Rhythm Pharmaceuticals (RYTM) PT Raised to $143 at Wells Fargo

March 12, 2026 5:56 AM
Wells Fargo analyst Chris M. Carey raised the price target on Rhythm Pharmaceuticals (NASDAQ: RYTM) to $143.00 (from $136.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change